Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.79 USD | +6.41% | +3.98% | -20.31% |
Apr. 05 | Hillevax Insider Sold Shares Worth $264,467, According to a Recent SEC Filing | MT |
Mar. 21 | Stifel Adjusts HilleVax Price Target to $34 From $30, Maintains Buy Rating | MT |
Evolution of the average Target Price on HilleVax, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering HilleVax, Inc.
Stifel Nicolaus | |
HC Wainwright | |
JPMorgan Chase | |
Guggenheim | |
SVB Securities LLC |
EPS Revisions
- Stock Market
- Equities
- HLVX Stock
- Consensus HilleVax, Inc.